InvestorsHub Logo
Followers 14
Posts 1420
Boards Moderated 0
Alias Born 06/10/2012

Re: None

Friday, 02/09/2024 6:42:22 PM

Friday, February 09, 2024 6:42:22 PM

Post# of 118360
8k out...Item 8.01 Other Events.

On February 7, 2024 Regen Biopharma, Inc. filed a provisional patent application with the United States Patent and Trademark Office covering compositions of matter, protocols and treatment means for accelerating hematopoietic reconstitution after an insult or chronic pathology by administration of stem cell derived endothelial progenitor cells or endothelial cells